相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of macrolide therapy in chronic obstructive pulmonary disease
Fernando Martinez
International Journal of Chronic Obstructive Pulmonary Disease (2016)
Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents
Akihiro Sugawara et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia
F. Cardinale et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Pharmacogenomics and adverse drug reactions: the case of statins
Mariano A. Giorgi et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Adjunctive Effects of Cyclosporine and Macrolide in Rapidly Progressive Cryptogenic Organizing Pneumonia with no Prompt Response to Steroid
Jaehee Lee et al.
INTERNAL MEDICINE (2011)
Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review
Yun Cai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia
Diego Viasus et al.
JOURNAL OF INFECTION (2011)
Infection With Highly Pathogenic H7 Influenza Viruses Results in an Attenuated Proinflammatory Cytokine and Chemokine Response Early After Infection
Jessica A. Belser et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Effects of immunomodulatory drugs on plasma inflammatory markers in a rabbit model of atherosclerosis
Maha E. Houssen et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2011)
Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro
Nikola Marjanovic et al.
PHARMACOLOGICAL RESEARCH (2011)
Immunomodulatory Effects of Macrolide Antibiotics - Part 2: Advantages and Disadvantages of Long-Term, Low-Dose Macrolide Therapy
J. Altenburg et al.
RESPIRATION (2011)
Immunomodulatory Effects of Macrolide Antibiotics - Part 1: Biological Mechanisms
J. Altenburg et al.
RESPIRATION (2011)
Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations
D. J. Serisier et al.
RESPIRATORY MEDICINE (2011)
Azithromycin Alters Macrophage Phenotype and Pulmonary Compartmentalization during Lung Infection with Pseudomonas
David J. Feola et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Usefulness of Macrolides as Anti-Inflammatories in Respiratory Diseases
Daniel Sevilla-Sanchez et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2010)
Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
Soichiro Kanoh et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Update on Infection and Antibiotics in Asthma
Donald R. Rollins et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2010)
Azithromycin induces anti-viral responses in bronchial epithelial cells
V. Gielen et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa A Randomized Controlled Trial
Lisa Saiman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
A trial of clarithromycin for the treatment of suboptimally controlled asthma
E. Rand Sutherland et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Long-term daily high and low doses of azithromycin in children with cystic fibrosis: A randomized controlled trial
S. K. Kabra et al.
JOURNAL OF CYSTIC FIBROSIS (2010)
Long-term azithromycin therapy for bronchiolitis obliterans syndrome: Divide and conquer?
Robin Vos et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)
Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome
Raksha Jain et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)
Comparative Effectiveness of Macrolides and Quinolones for Patients Hospitalized With Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)
Michael B. Rothberg et al.
JOURNAL OF HOSPITAL MEDICINE (2010)
Cytokine Profiles Induced by the Novel Swine-Origin Influenza A/H1N1 Virus: Implications for Treatment Strategies
Patrick C. Y. Woo et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Antimicrobial and immunomodulatory effect of clarithromycin on macrolide-resistant Mycoplasma pneumoniae
Satoshi Kurata et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2010)
The indication and effectiveness of low-dose erythromycin therapy in pediatric patients with bronchial asthma
Seigo Korematsu et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2010)
Effect of 6 Months of Erythromycin Treatment on Inflammatory Cells in Induced Sputum and Exacerbations in Chronic Obstructive Pulmonary Disease
Zhi-Yi He et al.
RESPIRATION (2010)
GSTM1 AND GSTT1 GENES ANALYSIS IN HEAD AND NECK CANCER PATIENTS
Cassia Veridiana Dourado Leme et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2010)
Macrolide antibiotics improve chemotactic and phagocytic capacity as well as reduce inflammation in sulfur mustard-exposed monocytes
Xiugong Gao et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy
Francesco Blasi et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitior
Chuanfu Zhang et al.
VIROLOGY JOURNAL (2010)
Immunomodulatory Properties of Antibiotics
R. Nau et al.
Current Molecular Pharmacology (2010)
Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis
Avraham Beigelman et al.
RESPIRATORY RESEARCH (2010)
Clarithromycin Prevents Smoke-induced Emphysema in Mice
Yutaka Nakanishi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Effects of Azithromycin on Glutathione S-Transferases in Cystic Fibrosis Airway Cells
Gabriella Bergamini et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Large Sequence Polymorphisms Unveil the Phylogenetic Relationship of Environmental and Pathogenic Mycobacteria Related to Mycobacterium ulcerans
Michael Kaeser et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2009)
Azithromycin Attenuates Airway Inflammation in a Noninfectious Mouse Model of Allergic Asthma
Avraham Beigelman et al.
CHEST (2009)
Safety Profile of the Respiratory Fluoroquinolone Moxifloxacin Comparison with Other Fluoroquinolones and Other Antibacterial Classes
Francoise Van Bambeke et al.
DRUG SAFETY (2009)
Pharmacological Treatment Options for Bronchiectasis Focus on Antimicrobial and Anti-Inflammatory Agents
Jonathan Ilowite et al.
DRUGS (2009)
Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma
Boska Hrvacic et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Long-term macrolide therapy in chronic inflammatory airway diseases
P. A. J. Crosbie et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
THE MACROLIDE CLARITHROMYCIN INHIBITS EXPERIMENTAL POST-TRANSPLANT BRONCHIOLITIS OBLITERANS
K. Remund et al.
EXPERIMENTAL LUNG RESEARCH (2009)
AZITHROMYCIN INCREASES CHLORIDE EFFLUX FROM CYSTIC FIBROSIS AIRWAY EPITHELIAL CELLS
Igor Oliynyk et al.
EXPERIMENTAL LUNG RESEARCH (2009)
Tetracyclines and Chemically Modified Tetracycline-3 (CMT-3) Modulate Cytokine Secretion by Lipopolysaccharide-Stimulated Whole Blood
Julia Cazalis et al.
INFLAMMATION (2009)
Azithromycin increases survival and reduces lung inflammation in cystic fibrosis mice
Wan C. Tsai et al.
INFLAMMATION RESEARCH (2009)
In vitro effects of erythromycin on RANKL and nuclear factor-kappa B by human TNF-α stimulated Jurkat cells
Lan Wu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study)
Enno Jacobs et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005
James A. Karlowsky et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice
Ximena Gavilanes et al.
JOURNAL OF CYSTIC FIBROSIS (2009)
Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients
C. R. Hansen et al.
Journal of Cystic Fibrosis (2009)
Anti-inflammatory drug therapy in asthma
Bart L. Rottier et al.
PAEDIATRIC RESPIRATORY REVIEWS (2009)
Azithromycin Treatment Alters Gene Expression in Inflammatory, Lipid Metabolism, and Cell Cycle Pathways in Well-Differentiated Human Airway Epithelia
Carla Maria P. Ribeiro et al.
PLOS ONE (2009)
Systems-Level Comparison of Host-Responses Elicited by Avian H5N1 and Seasonal H1N1 Influenza Viruses in Primary Human Macrophages
Suki M. Y. Lee et al.
PLOS ONE (2009)
Effects of prolonged use of azithromycin in patients with cystic fibrosis: A meta-analysis
D. F. Florescu et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2009)
Clarithromycin targets neutrophilic airway inflammation in refractory asthma
Jodie L. Simpson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Long-term Erythromycin Therapy Is Associated with Decreased Chronic Obstructive Pulmonary Disease Exacerbations
Terence A. R. Seemungal et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Antibiotic Prophylaxis for Chronic Obstructive Pulmonary Disease Resurrecting an Old Idea
Ken M. Kunisaki et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Clarithromycin inhibits progeny virus production from human influenza virus-infected host cells
Daisei Miyamoto et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Effect of maintenance azithromycin on established bronchiolitis obliterans syndrome in lung transplant patients
Nancy R. Porhownik et al.
CANADIAN RESPIRATORY JOURNAL (2008)
Effects of telithromycin in in vitro and in vivo models of lipopolysaccharide-induced airway inflammation
Magdalena Leiva et al.
CHEST (2008)
Lung transplantation: The role of azithromycin in the management of patients with bronchiolitis obliterans syndrome
A. M. Fietta et al.
CURRENT MEDICINAL CHEMISTRY (2008)
The clinical utility of biomarkers in asthma and COPD
Noel Snell et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Macrolides as immunomodulatory medications for the therapy of chronic lung diseases
Yolanda S. Lopez-Boado et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy
B. M. Vanaudenaerde et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
EM703, a new derivative of erythromycin, inhibits transforming growth factor-beta signaling in human lung fibroblasts
ChangHe Yu et al.
EXPERIMENTAL LUNG RESEARCH (2008)
Telithromycin inhibits the production of proinflammatory mediators and the activation of NF-κB in in vitro-stimulated murine cells
Magdalena Leiva et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2008)
Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response
Taronna R. Maines et al.
IMMUNOLOGICAL REVIEWS (2008)
Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Effect of Long-Term and Low-Dose Administration of Erythromycin on Proliferation of T Lymphocytes Stimulated with Mitogens
S. Harita et al.
JOURNAL OF CHEMOTHERAPY (2008)
Effect of Clarithromycin on Lung Inflammation and Alveolar Macrophage Function in Klebsiella pneumoniae B5055-Induced Acute Lung Infection in BALB/c mice
V. Kumar et al.
JOURNAL OF CHEMOTHERAPY (2008)
Immunomodulatory effect of three-day continuous administration of clarithromycin for experimental sepsis due to multidrug-resistant Pseudomonas aeruginosa
F. Baziaka et al.
JOURNAL OF CHEMOTHERAPY (2008)
Routine use of extended-release clarithromycin tablets for short-course treatment of acute exacerbations of non-severe COPD
P. Leophonte et al.
MEDECINE ET MALADIES INFECTIEUSES (2008)
Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004)
Matsuhisa Inoue et al.
MICROBIAL DRUG RESISTANCE (2008)
Macrolide antibiotics as immunomodulatory medications: Proposed mechanisms of action
Masaharu Shinkai et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis
G. A. Anwar et al.
RESPIRATORY MEDICINE (2008)
Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection
Gratiana Steinkamp et al.
RESPIRATORY MEDICINE (2008)
Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation
Jens Gottlieb et al.
TRANSPLANTATION (2008)
Suppression of oxidant-induced glutathione synthesis by erythromycin in human bronchial epithelial cells
Zhiyi He et al.
RESPIRATION (2008)
Effects of azithromycin on the expression of ATP binding cassette transporters in epithelial cells from the airways of cystic fibrosis patients
C. Cigana et al.
JOURNAL OF CHEMOTHERAPY (2007)
Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice
Francesco Blasi et al.
RESPIRATORY RESEARCH (2007)
Daily versus weekly azithromycin in cystic fibrosis patients
J. McCormack et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Clarithromycin has an immunomodulatory effect on ERK-mediated inflammation induced by Pseudomonas aeruginosa flagellin
Masaharu Shinkai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis
I. I. Siempos et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes
Dao Nguyen et al.
PEDIATRIC PULMONOLOGY (2007)
Macrolides in cystic fibrosis
John R. McArdle et al.
CLINICS IN CHEST MEDICINE (2007)
Antibiotics for the treatment of asthma
Peter N. Black
CURRENT OPINION IN PHARMACOLOGY (2007)
Evolution of Mycobacterium ulcerans and other mycolactone-producing mycobacteria from a common Mycobacterium marinum progenitor
Marcus J. Yip et al.
JOURNAL OF BACTERIOLOGY (2007)
Azithromycin reduces bronchial hyperresponsiveness and neutrophilic airway inflammation in asthmatic children: A preliminary report
Giorgio L. Piacentini et al.
ALLERGY AND ASTHMA PROCEEDINGS (2007)
Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells
Cristina Cigana et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Roxithromycin inhibits tumor necrosis factor-α-induced matrix metalloproteinase-1 expression through regulating mitogen-activated protein kinase phosphorylation and Ets-1 expression
T. Oyama et al.
JOURNAL OF PERIODONTAL RESEARCH (2007)
Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis
Mark Gotfried et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-κB activation in a cystic fibrosis epithelial cell line
Hannah Blau et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Maintenance azithromycin treatment in pediatric patients with cystic fibrosis - Long-term outcomes related to macrolide resistance and pulmonary function
Gerdien A. Tramper-Stranders et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial
F. Tahan et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis
Marcus Zervos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Novel Strategies for the Treatment of Asthma
Hajime Takizawa
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY (2007)
Immunomodulatory effects of erythromycin and its derivatives on human T-lymphocyte in vitro
Lan Wu et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2007)
Antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD)
P. -R. Burgel
MEDECINE ET MALADIES INFECTIEUSES (2006)
Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae
Miika Bergman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice
Rachida Legssyer et al.
RESPIRATORY RESEARCH (2006)
Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial
A. Clement et al.
THORAX (2006)
Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome
Geert M. Verleden et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Pulmonary biomarkers in chronic obstructive pulmonary disease
Peter J. Barnes et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice
Vanesa Ivetic Tkalcevic et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Telithromycin in lower respiratory tract infections
F. Blasi et al.
FUTURE MICROBIOLOGY (2006)
The effect of telithromycin in acute exacerbations of asthma
SL Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis
EB Wilms et al.
THERAPEUTIC DRUG MONITORING (2006)
Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis
SJ Phaff et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Exploring the mechanisms of macrolides in cystic fibrosis
AC Equi et al.
RESPIRATORY MEDICINE (2006)
Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis
E Yalçin et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2006)
Erythromycin exerts in vivo anti-inflammatory activity downregulating cell adhesion molecule expression
MJ Sanz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis
P Beringer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats
A Tone et al.
DIABETOLOGIA (2005)
Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model
J Steinberg et al.
SHOCK (2005)
Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome
B Yates et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients
D Shitrit et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Effect of azithromycin on bronchiectasis and pulmonary function in a heart-lung transplant patient with severe chronic allograft dysfunction: A case report
GM Verleden et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients
T Wagner et al.
CHEST (2005)
Standardisation of spirometry
MR Miller et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease
M Miravitlles et al.
RESPIRATORY MEDICINE (2005)
Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment
MJ Parnham et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Antiinflammatory therapies for cystic fibrosis: Past, present, and future
WA Prescott et al.
PHARMACOTHERAPY (2005)
Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study
M Khalid et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD
D Banerjee et al.
RESPIRATORY MEDICINE (2005)
Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis
M Gotfried et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Macrolides in the treatment of asthma and cystic fibrosis
G Ferrara et al.
RESPIRATORY MEDICINE (2005)
Anti-inflammatory effects of macrolides - an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
GW Amsden
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma
E Kostadima et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease
AL Pukhalsky et al.
MEDIATORS OF INFLAMMATION (2004)
Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis
R Wilson et al.
CHEST (2004)
Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors
M Kobayashi et al.
CELLULAR IMMUNOLOGY (2004)
Immunomodulatory activity and effectiveness of macrolides in chronic airway disease
BK Rubin et al.
CHEST (2004)
A locally active antiinflammatory macrolide (MLD987) for inhalation therapy of asthma
R Hersperger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Oral erythromycin and the risk of sudden death from cardiac causes
WA Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: Preliminary data
I Basyigit et al.
ANNALS OF PHARMACOTHERAPY (2004)
Azithromycin for improving pulmonary function in cystic fibrosis
RR Carr et al.
ANNALS OF PHARMACOTHERAPY (2004)
Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval
H Lode et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Efficacy of long-term macrolide antibiotic therapy in patients with diffuse panbronchiolitis: comparison between HLA-B54-positive and -negative cases
J Kadota et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
The nature of small-airway obstruction in chronic obstructive pulmonary disease
JC Hogg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The effect of long-term treatment with erythromycin on Th1 and Th2 cytokines in diffuse panbronchiolitis
SJ Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Azithromycin for cystic fibrosis
KW Southern et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
The use of macrolide antibiotics in patients with cystic fibrosis
L Saiman
CURRENT OPINION IN PULMONARY MEDICINE (2004)
Emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin:: a randomized, double-blind, placebo-controlled study
HF Berg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Role of chemically modified tetracycline on TNF-α and mitogen-activated protein kinases in sepsis
SR Maitra et al.
SHOCK (2004)
Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation
GM Verleden et al.
TRANSPLANTATION (2004)
Macrolide and occult infection in asthma
M Cazzola et al.
CURRENT OPINION IN PULMONARY MEDICINE (2004)
Azithromycin in, patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa -: A randomized controlled trial
L Saiman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis
Y Kaneko et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Human influenza A viruses are proteolytically activated and do not induce apoptosis in CACO-2 cells
O Zhirnov et al.
VIROLOGY (2003)
Roxithromycin promotes lymphocyte apoptosis in Dermatophagoides-sensitive asthma patients
N Ogawa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis
AJ White et al.
THORAX (2003)
The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome
T Tenson et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Temporal bone histopathology case of the month - Erythromycin ototoxicity
LJ McGhan et al.
OTOLOGY & NEUROTOLOGY (2003)
Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis
J Kadota et al.
RESPIRATORY MEDICINE (2003)
Maintenance azithromycin therapy for bronchiolitis obliterans syndrome - Results of a pilot study
SG Gerhardt et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis
GW Amsden et al.
CHEST (2003)
Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A
I Kobayashi et al.
RHEUMATOLOGY (2003)
Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin
P Nalepa et al.
CURRENT MEDICAL RESEARCH AND OPINION (2003)
An open-label, randomized, multicenter, comparative study of the efficacy and safety of 7 days of treatment with clarithromycin extended-release tablets versus clarithromycin immediate-release tablets for the treatment of patients with acute bacterial exacerbation of chronic bronchitis
K Weiss et al.
CLINICAL THERAPEUTICS (2002)
Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial
A Equi et al.
LANCET (2002)
Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis
LR Weiss
CLINICAL THERAPEUTICS (2002)
Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations
IS Patel et al.
THORAX (2002)
New strains of bacteria and exacerbations of chronic obstructive pulmonary disease
S Sethi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics
WA Volberg et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
M Miravitlles
EUROPEAN RESPIRATORY JOURNAL (2002)
Rapid increase in macrolide resistance among penicillin non-susceptible pneumococci in Finland, 1996-2000
M Pihlajamäki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes
R Wilson et al.
CLINICAL THERAPEUTICS (2002)
Bronchiolitis obliterans organizing pneumonia: Clinicopathologic review of a series of 45 Korean patients including rapidly progressive form
J Chang et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2002)
Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study
JM Corne et al.
LANCET (2002)
Effect of topical immunomodulators on acute allergic inflammation and bronchial hyperresponsiveness in sensitised rats
TJ Huang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection model
A Kutlin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Therapy with macrolides in patients with cystic fibrosis
AS Gaylor et al.
PHARMACOTHERAPY (2002)
Successful treatment of a case with rapidly progressive bronchiolitis obliterans organizing pneumonia (BOOP) using cyclosporin A and corticosteroid
D Koinuma et al.
INTERNAL MEDICINE (2002)
Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial
J Wolter et al.
THORAX (2002)
Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae
C Garcia-Rey et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma
A Ekici et al.
JOURNAL OF ASTHMA (2002)
Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study
JD Spahn et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2001)
The effect of erythromycin on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum
Y Shibuya et al.
RESPIRATION (2001)
Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae
PN Black et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Evaluation of blood vessels and edema in the airways of asthma patients - Regulation with clarithromycin treatment
HW Chu et al.
CHEST (2001)
Anti-inflammatory effects of macrolides in lung disease
A Jaffé et al.
PEDIATRIC PULMONOLOGY (2001)
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
S Gompertz et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro
E Sato et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
MLS resistance phenotypes and mechanisms in beta-haemolytic group B, C and G Streptococcus isolates in La Rioja, Spain
A Portillo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Long-term clarithromycin decreases prednisone requirements in elderly patients with prednisone-dependent asthma
KW Garey et al.
CHEST (2000)
Effects of roxithromycin on tumor necrosis factor-alpha-induced vascular endothelial growth factor expression in human periodontal ligament cells in culture
T Oyama et al.
JOURNAL OF PERIODONTOLOGY (2000)
The use of immunosuppressive macrolides in clinical dermatology
EC Bornhövd et al.
HAUTARZT (2000)
Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma
H Amayasu et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2000)
Acute exacerbation of COPD - Factors associated with poor treatment outcome
NA Dewan et al.
CHEST (2000)
Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells
S Abe et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)
分享论文
